Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193534 | SCV000247659 | uncertain significance | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002227092 | SCV002506508 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of this particular variant (rs201264306) in MODY yet. | |
Fulgent Genetics, |
RCV002478671 | SCV002782781 | uncertain significance | Diabetes mellitus, transient neonatal, 3; Hyperinsulinemic hypoglycemia, familial, 2; Type 2 diabetes mellitus; Maturity-onset diabetes of the young type 13; Diabetes mellitus, permanent neonatal 2 | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV003884391 | SCV004698178 | uncertain significance | Maturity-onset diabetes of the young type 13 | criteria provided, single submitter | research | Potent mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of this particular variant rs72554079 in MODY yet. |